Overdiagnosis and Breast Cancer Screening Decisions

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

July 23, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Mammography ScreeningGeriatricsDecision Aid
Interventions
BEHAVIORAL

Breast cancer screening decision aid -- low risk

Participants in this study will view a video-based decision aid that describes the risks and benefits of breast cancer screening for older women. Participants assigned to the low risk of overdiagnosis arm will view a version of the decision aid the describes a low risk of overdiagnosis.

BEHAVIORAL

Breast cancer decision aid -- moderate risk

Participants in this study will view a video-based decision aid that describes the risks and benefits of breast cancer screening for older women. Participants assigned to the moderate risk of overdiagnosis arm will view a version of the decision aid the describes a moderate risk of overdiagnosis.

BEHAVIORAL

Breast cancer screening decision aid -- high risk

Participants in this study will view a video-based decision aid that describes the risks and benefits of breast cancer screening for older women. Participants assigned to the high risk of overdiagnosis arm will view a version of the decision aid the describes a high risk of overdiagnosis.

OTHER

Control condition

Participants in this study will view a video-based decision aid that describes the risks and benefits of breast cancer screening for older women. Participants assigned to the control arm will view a version of the decision aid that does not contain any information about overdiagnosis.

Trial Locations (1)

06511

RECRUITING

Yale School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER

NCT07071415 - Overdiagnosis and Breast Cancer Screening Decisions | Biotech Hunter | Biotech Hunter